Globus Medical

Yahoo Finance • 2 days ago

Robotic Neurosurgery Market Analysis and Forecast Report 2025-2035, with Profiles of Brainlab, Renishaw, Zimmer Biomet, Medical Microinstruments, Monteris Medical, Medtronic, Globus Medical, & Accuray

Dublin, Sept. 29, 2025 (GLOBE NEWSWIRE) -- The "Robotic Neurosurgery Market - A Global and Regional Analysis: Focus on Application, Product Type, End User, and Regional Analysis - Analysis and Forecast, 2025-2035" report has been added t... Full story

Yahoo Finance • last month

Globus Medical wins favorable jury verdict in patent dispute with Life Spine

[Gavel on desk] CatLane A Delaware jury has sided with Globus Medical (NYSE:GMED [https://seekingalpha.com/symbol/GMED]), issuing a verdict in favor of the orthopedic product maker in a patent infringement case against its rival Life Spin... Full story

Yahoo Finance • last month

Globus Medical, Inc. Secures Jury Verdict in Delaware Patent Litigation Against Life Spine, Inc.

AUDUBON, Pa., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, announced that a Delaware jury has returned a verdict in favor of Globus in its patent infringement litigati... Full story

Yahoo Finance • last month

Citizens JMP reiterates Market Perform rating on Globus Medical stock

Investing.com - Citizens JMP has reiterated its Market Perform rating on Globus Medical (NYSE:GMED) following the release of the company’s second-quarter 2025 results. According to InvestingPro analysis, the company currently appears und... Full story

Yahoo Finance • 2 months ago

Globus Medical Inc - A (NYSE:GMED): A Prime Example of Affordable Growth with Strong Fundamentals

Growth investing typically focuses on companies with significant revenue and earnings increases, though prices may sometimes reach unrealistic heights. The "Affordable Growth" method seeks to strike a balance by selecting stocks with solid... Full story

Yahoo Finance • 2 months ago

Barclays raises Globus Medical stock price target to $106 on margin strength

Investing.com - Barclays raised its price target on Globus Medical (NYSE:GMED) to $106.00 from $103.00 on Friday, while maintaining an Overweight rating on the medical device company’s stock. According to InvestingPro data, the stock cur... Full story

Yahoo Finance • 2 months ago

Globus Medical earnings beat by $0.10, revenue topped estimates

Investing.com - Globus Medical (NYSE: GMED) reported second quarter EPS of $0.86, $0.10 better than the analyst estimate of $0.76. Revenue for the quarter came in at $745.3M versus the consensus estimate of $739.16M. Guidance Globus Me... Full story

Yahoo Finance • 2 months ago

Globus Medical Reports Second Quarter 2025 Results

AUDUBON, Pa., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30, 2025. Worldwide net sales were $745.3 m... Full story

Yahoo Finance • 2 months ago

Square, Gilead, Monster Beverage set to report earnings Thursday

Earnings season continues as we highlight companies expected to report earnings the next trading day, helping investors prepare for the upcoming market action. Leading the charge are Square, Gilead Sciences, and Monster Beverage (NASDAQ:... Full story

Yahoo Finance • 2 months ago

Canaccord Downgrades Globus Medical (GMED) PT to $90, Maintains Buy Rating

Globus Medical Inc. (NYSE:GMED) is one of the most undervalued stocks to buy and hold for 3 years. On July 22, Canaccord reduced its price target for Globus Medical from $97 to $90 while maintaining a Buy rating. The adjustment showed Cana... Full story

Yahoo Finance • 2 months ago

Globus Medical stock holds steady as Needham maintains rating amid CEO change

Investing.com - Needham maintained its Hold rating on Globus Medical (NYSE:GMED), a $7.2 billion medical device company currently trading near its 52-week low, following the company’s announcement of a CEO transition and preliminary seco... Full story

Yahoo Finance • 2 months ago

Globus Medical stock hits 52-week low at 53.54 USD

Globus Medical (NYSE:GMED) stock reached a 52-week low, touching down at 53.54 USD, reflecting a challenging period for the company. According to InvestingPro analysis, the stock appears undervalued at current levels, with strong fundamen... Full story

Yahoo Finance • 2 months ago

Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer

CHARLOTTE, N.C., July 21, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or “the Company”) (Nasdaq: XRAY) today announced that Daniel Scavilla, an established business leader with more than three decades of experience i... Full story

Yahoo Finance • 2 months ago

Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results

AUDUBON, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced that Keith Pfeil, Executive Vice President, Chief Operating Officer and Chief Financial Offi... Full story

Yahoo Finance • 2 months ago

Globus Medical Schedules Second Quarter Earnings Release and Conference Call

AUDUBON, Pa., July 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the second quarter ended June 30, 2025 after the market close on Thur... Full story

Yahoo Finance • 2 months ago

Piper Sandler Maintained a Buy Rating on Globus Medical (GMED), Kept the PT Unchanged

Globus Medical, Inc. (NYSE:GMED) is one of the Best 52-Week Low Stocks to Buy According to Analysts. On July 3, Piper Sandler analyst Matthew O’Brien maintained a Buy rating on Globus Medical, Inc. (NYSE:GMED) with a price target of $80.... Full story

Yahoo Finance • 3 months ago

Globus Medical expands navigation capabilities with new DuraPro system

AUDUBON, Pa. - Globus Medical, Inc. (NYSE:GMED), a $7.56 billion medical device company currently trading near its 52-week low, announced Tuesday the expansion of its Excelsius navigation capabilities with the introduction of its DuraPro o... Full story

Yahoo Finance • 3 months ago

Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue

AUDUBON, Pa., July 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the expanded Excelsius™ navigation capabilities of its next-generation oscillating system, Du... Full story

Yahoo Finance • 3 months ago

Globus Medical (GMED) Fell 19% in Q2

Headwaters Capital Management, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The portfolio bounced back from the first quarter uncertainty and, like the res... Full story

Yahoo Finance • 3 months ago

Piper Sandler maintains Overweight rating on Globus Medical stock

Investing.com - Piper Sandler has reiterated its Overweight rating and $80.00 price target on Globus Medical (NYSE:GMED) despite the stock being one of the worst performers in the medical device sector this year, with shares down nearly... Full story